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What is known about the topic?
 • The global COVID-19 pandemic is a consequence of the rapid spread of the SARS-CoV-2 
virus and cleaning is essential in breaking the cycle of infection.
 • There is limited specific guidance regarding the proper disinfection methods that 
should be used.
What does the study add?
 • Our review included 27 studies which inoculated SARS-CoV-2 virus onto different types 
of material including masks, nasopharyngeal swabs, serum, laboratory plates and sim-
ulated saliva, tears or nasal fluid, and then interventions were applied in an attempt to 
eliminate the virus.
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Abstract
Background: Cleaning is a major control component for outbreaks of infection. However, for 
the SARS-CoV-2 pandemic, there is limited specific guidance regarding the proper disinfection 
methods that should be used.
Methods: We conducted a systematic review of the literature on cleaning, disinfection or 
decontamination methods in the prevention of SARS-CoV-2.
Results: A total of 27 studies were included, reporting a variety of methods with which the 
effectiveness of interventions were assessed. Virus was inoculated onto different types of 
material including masks, nasopharyngeal swabs, serum, laboratory plates and simulated 
saliva, tears or nasal fluid and then interventions were applied in an attempt to eliminate 
the virus including chemical, ultraviolet (UV) light irradiation, and heat and humidity. At body 
temperature (37°C) there is evidence that the virus will not be detectable after 2 days but this 
can be reduced to non-detection at 30 min at 56°C, 15 min at 65°C and 2 min at 98°C. Different 
experimental methods testing UV light have shown that it can inactivate the virus. Light of 
254–365 nm has been used, including simulated sunlight. Many chemical agents including 
bleach, hand sanitiser, hand wash, soap, ethanol, isopropanol, guandinium thiocynate/t-
octylphenoxypolyethoxyethanol, formaldehyde, povidone-iodine, 0.05% chlorhexidine, 0.1% 
benzalkonium chloride, acidic electrolysed water, Clyraguard copper iodine complex and 
hydrogen peroxide vapour have been shown to disinfect SARS-CoV-2.
Conclusions: Heating, UV light irradiation and chemicals can be used to inactivate SARS-CoV-2 
but there is insufficient evidence to support one measure over others in clinical practice.
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 • Several methods are effective in inactivating the SARS-CoV-2 virus, with these methods 
broadly classed as those related to heating, UV light irradiation and chemical agents.
 • All of the studies took place in laboratory settings rather than real-life clinical settings, 
so there is insufficient evidence to recommend one type of cleaning procedure over 
another.
Introduction
As of November 2020, there have been more than 
1.3 million deaths attributed to SARS-CoV-2.1 
The global COVID-19 pandemic is believed to 
have originated in Wuhan, China in December 
2019 and is a consequence of the rapid spread of 
the SARS-CoV-2 virus.2 Current evidence suggests 
that this virus is primarily transmitted between peo-
ple through respiratory droplets and contact 
routes.3 Cleaning and disinfection is essential in 
breaking the cycle of infection so that the surfaces 
and objects which may be in contact with infected 
patients are decontaminated. While methods have 
been advised to protect oneself from COVID-19 
including the washing of hands frequently, avoid-
ing close contact, covering the nose and mouth 
with a mask, cleaning and disinfection,4 infected 
patients may still be spreading the illness in the 
community and in healthcare settings despite 
adherence to these methods. In hospital settings, 
where there is inevitable contact with patients 
infected with COVID-19, it is of critical impor-
tance that equipment and facilities are cleaned to 
avoid infecting healthcare staff and other patients. 
There is limited specific guidance regarding the 
proper disinfection methods that should be used.
Many studies have evaluated the reduction of 
SARS-CoV-2 using thermal, irradiation and 
chemical methods. Early studies of viral decon-
tamination focused on N95 respirators because of 
concerns over inadequate supplies of personal pro-
tective equipment in outbreak areas. There were 
also concerns that this new virus may have differ-
ent response to different methods of decontamina-
tion depending on the environment, including 
factors such as humidity, temperature and irradia-
tion. The most commonly used measure to reduce 
viral transmission is application of chemical meth-
ods in the form of hand sanitiser or hand wash.
While the efficacy of different methods to clean and 
disinfect viruses has been previously studied, the 
extent to which these agents work for SARS-CoV-2 
is less known. We therefore conducted a systematic 
review of cleaning and decontamination methods 




We selected studies that evaluated the cleaning, 
disinfection or decontamination of SARS-CoV-2. 
There were no restrictions on what type of meas-
ure was used but the study had to evaluate the 
effectiveness of the measure on inactivating or 
eradicating SARS-CoV-2. There was no restric-
tion based on study design, cohort type or lan-
guage of the report, but original data had to be 
presented.
Search strategy
We searched MEDLINE and EMBASE using 
OVID with no date or language restriction in 
November 2020. The exact search terms were: 
(cleaning OR disinfection OR decontamination) 
AND (COVID-19 OR SARS-CoV-2). We 
reviewed the bibliography of relevant studies and 
reviews for additional studies that met the inclu-
sion criteria.
Study selection and data extraction
Three reviewers screened all titles and abstracts 
retrieved from the search for studies that met 
the inclusion criteria. The studies that poten-
tially met the inclusion criteria were reviewed 
and the final decision to include or exclude 
studies was made by consensus. Data were col-
lected on the substrate of SARS-CoV-2 testing, 
the method of decontamination or disinfection 
and study results.
Data analysis
Data were extracted into pre-designed and piloted 
tables. Study findings were narratively synthesised. 
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Considerable heterogeneity in the study methodol-
ogy meant that we did not perform statistical pool-
ing or meta-analysis. However, the data were 
grouped according to type of measure to disinfect 
SARS-CoV-2 which included heat and humidity, 
light irradiation and chemical agents.
Results
A total of 27 studies were included in this review 
after screening and reviewing potentially relevant 
studies (as shown in Figure 1).5–31
The description of the substrates for testing 
SARS-CoV-2 and methods for decontamination 
or disinfection are shown in Tables 1–3. Most 
studies used Vero E6 cells to culture SARS-
CoV-2 and some studies inoculated the virus 
onto masks, nasoapharyngeal swabs, serum, labo-
ratory plates and simulated saliva, tears or nasal 
fluid. The methods used to eliminate virus 
included heat, humidity, light irradiation and 
chemical treatments.
Heat and humidity
The results of studies that evaluated the effect of 
heat and humidity on SARS-CoV-2 are shown in 
Table 1. Chin et al.9 studied the stability of the 
virus at different temperatures and found that it 
could be detected beyond 14 days at 4°C but not 
detectable after 2 days at 37°C. With respect to 
different surfaces, the virus could be detected for 
3 h on paper or tissue paper and up to 7 days on 
stainless steel, plastic and masks. Heat inactiva-
tion of the virus was reported to take place at 
2 min at 98°C, 10–15 min at 60–65°C, 15–30 min 
at 56°C, and 48 h at 42°C.5,6,30 Heating N95 
masks at 70°C was reported by two studies to be 
effective in decontaminating the virus.10,11 The 
conditions of heating appear to be important, as 
Gamble et al.12 found that the virus was not 
detected at 30 min in a closed 2 ml vial that was 
heated to 70°C, but if tested in a covered or 
uncovered plate in an oven the time needed to 
achieve decontamination increased (90 and 
60 min, respectively). Also Campos et al.7 evalu-
ated the influence of humidity and temperature, 
Figure 1. Flow diagram of study selection
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Table 1. Results from included studies for heat and humidity.
Study ID Substrate of SARS-CoV-2 tested Results
Auerswald et al.5 Vero E6 cells were used to culture SARS-
CoV-2.
Results all methods inactivated the viruses:
 • Heat at 56°C for 30 min
 • Heat at 56°C for 60 min
 • Heat at 98°C for 2 min
Batéjat et al.6 Vero E6 cells were used to culture SARS-
CoV-2 on cell culture supernatants, 
nasopharngeal swab and serum.
Heated cell culture supernatant:
 • 56°C not detected at 30 min
 • 65°C not detected at 15 min
 • Heated nasopharyngeal swab:
 • 65°C not detected at 10 min
 • 95°C not detected 15 min
Heated serum:
 • 56°C not detected at 15 min
Campos et al.7 Droplet of SARS-CoV-2 (1 × 106 PFU/
sample) placed on meltblown fabric from 
N95-grade filtering facepiece respirators.
Reduction from 25°C in log 10:
 • Ambient humidity (60%)–BSA: 60°C 30 min 2.16 ± 0.23, 75°C 30 min 
3.69 ± 0.32, 85°C 20 min >4.77, 95°C 5 min >4.77
 • Ambient humidity (60%) + BSA: 60°C 30 min 1.07 ± 0.06, 75°C 30 min 
2.89 ± 0.31, 85°C 20 min 4.3 ± 0.55, 95°C 5 min 4.8 ± 0.44
 • 100% humidity–BSA: 60°C 30 min 2.82 ± 0.09, 75°C 30 min >4.97, 85°C 
20 min >4.97, 95°C 5 min >4.97
 • 100% humidity + BSA: 60°C 30 min 2.27 ± 0.09, 75°C 30 min 4.92 ± 0.12, 
85°C 20 min >5.02, 95°C 5 min >5.02
Chin et al.9 SAR-CoV-2 culture (7.8 log unit of 
TCID50/ml) 15 μl droplet pipetted on 
surfaces with 200 μl virus transport 
medium and 135 μl of disinfectants.
At different temperatures:
4°C virus detected after 14 days
22°C virus not detected at 14 days
37°C virus not detected at 2 days
56°C virus not detected at 30 mins
70°C virus not detected at 5 min
Surfaces and when virus undetected:
 • Paper 3 h
 • Tissue paper 3 h
 • Wood 2 days
 • Cloth 2 days
 • Glass 4 days
 • Banknote 4 days
 • Stainless steel 7 days
 • Plastic 7 days
 • Mask inner 7 days
 • Mask outer layer detected at 7 days
Daeschler et al.10 4 N95 respirators models pieces and 
inoculated with 5 μl of SARS-CoV-2 (7.8 
log TCID50/ml).
 • Heating 70°C for 60 min virus was not detected
Fischer et al.11 Vero E6 cells inoculated on samples of 
N95 masks and stainless steel surfaces.
Median time to one millionth (mins) for N95 mask and stainless steel:
 • Control 1.56 × 103 and 4.66 × 103 min
 • Heat 70°C 95.6 and 176 min
Gamble et al.12 SARS-CoV-2 suspension in culture 
medium which was heat treated in  
24-well plate and closed vials.
Heat treatments at 70°C:
 • Uncovered 24-well plate in oven: virus reduced by 1 log10 TCID50/
ml at 60 min
 • Covered 24-well plate in oven: virus not detected at 90 min
 • Closed 2 ml vial in oven: virus not detected at 30 min
 • Closed 2 ml vial in water: virus not detected at 30 min
Wang et al.30 SARS-CoV-2 with infectious titre 1.4 × 107 
was heated at different temperatures.
Viral titres (TCID50/ml)
 • 37°C present at 24 h (1.8 × 106), 320 at 48 h
 • 42°C present at 60 min (1.9 × 106), undetectable at 48 h
 • 56°C undetectable at 30 min
 • 56°C in 50% human serum undetectable at 30 min
 • 60°C undetectable at 15 min
 • Unheated 1.4 × 107 at 120 min
PFU, plaque forming-unit; BSA, bovine serum albumin; TCID, tissue culture infective dose; .
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Table 2. Results from included studies for ultraviolet light irradiation.
Study ID Substrate of SARS-CoV-2 tested Results
Fischer et al.11 Vero E6 cells inoculated on samples 
of N95 masks and stainless steel 
surfaces.
Median time to one millionth (mins) for N95 mask and stainless steel:
 • Control 1.56 × 103 and 4.66 × 103 min
 • UV light 128 and 9.79 min
Helingloh et al.13 Vero E6 cells used to culture SARS-
CoV-2 (5 × 106 TCID50/ml) and 600 μl 
virus stock placed in 24-well plates.
 • UVC and UVA treatment: inactivation in 9 min. 50% reduction in 1.4 min 
with treatment
Inagaki et al.16 Vero E6 cells infected with SARS-
CoV-2 diluted with phosphate 
buffered saline and adjusted to 
2.0 × 104 plaque-forming units/ml 
and 150 μl were placed in a Petri dish 
and irradiated.
Infectious titre with different irradiation time with deep ultraviolet light 
(280 nm) (reduction ratio %, log PFU ratio):
 • 1 s 4.7 × 103 (87.4%, 0.9)
 • 10 s 2.7 × 101 (99.9%, 3.1)
 • 20 s 6.7 × 100 (99.9%, >3.3)
 • 30 s <20 (99.9%, >3.3)
Kitagawa et al.18 Vero E6 cells were infected with 
SARS-CoV-2 and viral suspension 
made with viral titres of 5 × 106 
TCID50/ml. 100 μl of viral suspension 
transferred on plates which were 
irradiated.
Mean viable SARS-CoV-2 by time (log reduction) with 222 nm UV 
disinfection:
 • Control 2.05 × 104
 • 10 s 2.34 ± 0.86 × 103 (0.94)
 • 30 s 6.32 ± 0.0 × 101 (2.51)
 • 60 s 6.32 ± 0.0 × 101 (2.51)
 • 300 s 6.32 ± 0.0 × 101 (2.51)
 • RNA did not change after UV irradiation compared with controls
Ozog et al.24 Vero-E6 cells were infected with 
SARS-CoV-2 virus. 10 μl drop of 
SARS-CoV-2 viral stock (8 × 107 
TCID50/ml) inoculated on four 
different locations of five different 
N95 filtering facepiece respirators.
Low-pressure mercury lamp ultraviolet germicidal irradiation device 
(254 nm) with irradiation for 60–70 s each side and log 10 TICD50/4 mm 
punch (300 μml) for location 1, 2, 3, 4 (range for respirator A, B and C) and 
control by mask type:
 • 3M 1860 <1.3, <1.3, <1.3, <1.3–2.28, 2.98–5.48
 • 3M 8210 <1.3–2.38, ⩽1.3, <1.3, <1.3, 2.38–5.48
 • Moldex 1511 <1.3, <1.3, <1.3, <1.3, 2.58–4.68
 • 3M 8511 <1.3, <1.3, ⩽1.3, 2.28–2.78, 3.38–4.48
 • 3M 9211 <1.3, <1.3, ⩽1.3, 2.28–2.78, 2.28–3.88
Rathnasinghe et al.25 Vero-E6 cells infected with SARS-
CoV-2 and virus was adsorbed to N95 
mask coupons and mask squares.
Infectious SARS-CoV-2 was not detected by plaque assays on N95 
respirator snippets when irradiated with UVC for 120 s per side or longer 
suggesting 3.5 log reduction in 240 s of irradiation
Ratnesar-Shumate et al.26 Vero cells infected with SARS-CoV-2 
with concentration 1.5 × 106 TCID50/
ml. Viral solution spike 1:10 on 
simulated saliva or complete growth 
medium.
With UVB irradiation of saliva, inactivation rates ranged from 0 in 
darkness to 0.15 log10 TCID50 loss/min
Ninety percent of infectious virus would be lost every 6.8, 8.0, and 
12.8 min for integrated UVB irradiances of 1.6, 0.7, and 0.3 W/m2
With UVB irradiation of growth medium, inactivation rates in ranged from 
0 in darkness to 0.07 log10 TCID50 loss/min.
Ninety percent of infectious virus would be lost every 14.3 and 17.6 min for 
integrated UVB irradiances of 1.6 and 0.7 W/m2, respectively
Inactivation rate of virus was greater when suspended in simulated saliva 
than growth medium
Simmons et al.27 Vero E6 cells infected with SARS-
CoV-2 with viral titre of 1.3 × 107 
plaque-forming units. 0.020 ml 
of virus deposited as droplet on 
chamber slide and N95 respirator, 
3M 1860).
Pulsed-xenon UV light on (log 10 PFU/ml)
 • Slide at 0 min 6.2
 • Slide at 1 min 2.67 (reduction 99.97%, log 10 3.53)
 • Slide at 2 min <1.66 (reduction >99.997%, log 10 >4.54)
 • Slide at 5 min <2.08 (reduction >99.992%, log 10 >4.12)
 • N95 respirator at 0 min 6.35
 • N95 respirator at 5 min <1.56 (reduction >99.998, >4.79)
Smith et al.28 Vero E6 cells infected with SARS-
CoV-2 inoculated on N95 masks 
(1860, 1870+, 8511).
Infectivity (ΔRNA in Vero E6 cells from input log 10) with 254 nm UV light 
on mask type:
 • 1860 log reduction of ~3
 • 1870+ log reduction of ~−2
 • 8511 log reduction of ~3
PFU, plaque forming-unit; UV, ultraviolet; UVC, ultraviolet C; UVB, ultraviolet B; UVA, ultraviolet A; RNA, ribonucleic acid.
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Table 3. Results from included studies for chemical or other agents.
Study ID Substrate of SARS-CoV-2 tested Results
Auerswald et al.5 Vero E6 cells were used to culture 
SARS-CoV-2.
Results all methods inactivated the viruses:
 • 560 μl of viral lysis buffer for 10 min at room temperature
 • 200 μl of inactiving sample buffer containing 50% guandinium thiocynate and 6% 
t-oxtylphenoxypolyethoxyethnaol for 15 min at room temperature
Chan et al.8 Vero E6 cells infected with  
SARS-CoV-2.
Log 10 reduction in virus at 1 and 5 min:
 • Ethanol (75%) ⩾1.83 ± 0.29 and ⩾2.00 ± 0.00
 • Bleach (10%) ⩾3.25 ± 0.00 and ⩾3.25 ± 0.00
 • Virkon (2%) ⩾3.00 ± 0.00 and ⩾3.00 ± 0.00
 • Formalin (10%) ⩾1.25 ± 0.00 and ⩾1.25 ± 0.00
 • Lysis buffer (EasyMAG) ⩾2.00 ± 0.43 and ⩾2.25 ± 0.00
 • AVL (viral lysis buffer, Qiagen) ⩾3.00 ± 0.43 versus ⩾3.25 ± 0.00
 • Liquid hand soap (Funchem) ⩾2.00 ± 1.56 versus ⩾2.25 ± 0.00
 • Hand wash (Mannings) ⩾0.83 ± 0.29 versus ⩾0.92 ± 0.38
 • Hand rub (WHO formulation I) ⩾2.17 ± 0.14 and ⩾2.25 ± 0.00
 • Advanced had sanitiser (Purell) ⩾2.50 ± 0.0 versus ⩾2.50 ± 0.00
 • Disinfecting solution (Dermo docyn) ⩾2.30 ± 0.50 and ⩾3.75 ± 0.43
 • Hand wash (Walch) ⩾0.83 ± 0.29 and ⩾0.92 ± 0.14
Chin et al.9 SAR-CoV-2 culture (7.8 log unit of 
TCID50/ml) 15 μl droplet pipetted on 
surfaces with 200 μl virus transport 
medium and 135 μl of disinfectants.
Household bleach (1:49), household bleach (1:99), pure ethanol (70%), povidone-
iodine (7.5%), chloroxylenol (0.05%), chlrohexidine (0.05%) and benzalkonium 
chloride (0.1%) all virus not detected at 5 mins
Hand soap (1:49) virus not detected at 15 min
Fischer et al.11 Vero E6 cells inoculated on samples 
of N95 masks and stainless steel 
surfaces.
Median time to one millionth (mins) for N95 mask and stainless steel:
 • Control 1.56 × 103 and 4.66 × 103 min
 • Ethanol (70%) 6.97 and 17.7 min
 • Vaporised hydrogen peroxide 10.1 and 8.55 min
Ibanez-Cervantes 
et al.14
SARS-CoV-2 undiluted and diluted 
1:10, 1:100, 1:1000, and 1:10000 
inoculated on N95 masks.
Hydrogen peroxide plasma after mask placed in sterilised bag results in virus not 
detected after treatment at all concentrations
Ijaz et al.15 SARS-CoV-2 suspension and dried on 
glass surface with 5% FBS organic 
load.
Log 10 reduction in infectious SARS-CoV-2 titre:
 • Antiseptic liquid (0.094 w/v para-chloro-meta-xylenol) for 5 min at 21°C ⩾4.7
 • Hand sanitiser gel (49% w/w ethanol) for 1 min at 21°C ⩾4.2
 • Liquid hand wash (0.025% w/w salicylic acid) for 1 min at 37°C ⩾3.1
 • Bar soap (0.018 w/w para-chloro-meta-xylenol) for 1 min at 38°C ⩾3.0
 • Surface cleanser (0.077 w/w QAC) for 5 min at 21°C ⩾4.1
 • Disinfectant wipes (0.19% w/w QAC) for 2 min at 21°C ⩾3.5
 • Disinfectant spray (50% w/w ethanol QAC) for 2 min at 21°C ⩾4.5
Jahromi et al.17 SARS-CoV-2 suspension prepared by 
infecting monolayers of A549 cells 
with viral titres 105–1010 TCID50/ml. 
10 μl inoculum was pipetted into test 
field and sanitising fluid was sprayed 
on.
Reduction factor:
 • Water <1
 • 70% ethanol/water ~5
 • 70% isopropanol/water ~5
 • 35% ethanol/35% isopropanol/water ~6
 • 35% ethanol/35% isopropanol/3% glycerin/water ~6
 • 3% SDBS/70% ethanol/water ~6
 • 3% SDBS/70% ethanol/3% glycerine/water ~6
 • 3% SLS/70% ethanol/water ~6
 • 3% hand soap/70% isopropanol/water ~6
 • 3% dish soap/70% ethanol/water ~7
 • 3% dish soap/35% ethanol/35% isopropanol/3% glycerin/water ~7
 • 3% dish soap/water <1
 • 3% hand soap/water <1
Kratzel et al.19 Vero E6 cells were infected with 
SARS-CoV-2 to prepare a viral 
suspension. Viral suspension 
mixed with 1:1 organic load and 1:8 
disinfectant solution for 30 s.
Log 10 reduction factor:
 • Original WHO formulation I (80% ethanol/1.45% glycerol/0.125% hydrogen 
peroxide) ⩾3.8
 • Modified WHO formulation I (80% ethanol, 0.725% glycerol/0.125% hydrogen 
peroxide) ⩾5.9
 • Original WHO formulation II (75% 2-propanolol 1.45% glycerol, 0.125% hydrogen 
peroxide) ⩾3.8
 • Modified WHO formulation II (75% 2-propanolol/0.725% glycerol/0.125% 
hydrogen peroxide) ⩾5.9
 • ⩾30% ethanol ⩾5.9
 • ⩾30% 2-propanolol ⩾5.9
(Continued)
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Study ID Substrate of SARS-CoV-2 tested Results
Kumar et al.20 Inoculum of 10 μl of viral suspension 
containing 6.5 log TCID50 SARS-CoV-2 
was spotted on N95 respirator masks 
(3M 1860, 3M Aura 1870, 3M Vflex 
1804S, AO Safety 1054S).
Standard autoclaving, vaporous hydrogen peroxide, peracetic acid dry fogging 
system, ethylene oxide gassing and low-temperature hydrogen peroxide gas 
plasma all resulted in ⩾6 log reduction of infectious virus on all treated masks
Autoclaving resulted in functional failure of the 3M 1860/8210 models after 3+ 
cycles, low-temperature hydrogen peroxide gas plasma all mask failed at 5+ cycles
Liang et al.21 Vero 76 cells infected with SARS-
CoV-2. Povidine iodine gels were 
tested at full strength (90% sample 
versus 10% virus solution), 1/1.8, 1/3.2 
and 1/10 dilution in simulated tears or 
nasal fluid incubated at 37°C for 30s, 
2 min and 10 min.
Log reduction value at 30s, 2 min and 10 min:
 • Control 0
 • 90% drug (1.0% Povidine iodine gel (PVP-I)) 3.5, 2.9, 3.3
 • 50% drug (1.0% PVP-I) 3.2, 2.9, 3.3
 • 28% drug (1.0% PVP-I) 2.2, 2.6, 3.3
 • 9% drug (1.0% PVP-I) 1.2, 0.8, 1
 • 90% drug (0.6% PVP-I) 3.1, 2.9, 3.3
 • 50% drug (0.6% PVP-I) 3.1, 2.9, 3.3
 • 28% drug (0.6% PVP-I) 2.9, 2.8, 3.3
 • 9% drug (0.6% PVP-I) 2.3, 1.9, 1.6
 • Ethanol 3.5, 1.9, 3.3
Mantlo et al.22 Vero cells infected with SARS-CoV-2 
with concentration of 1 × 106 TCID50/
ml. 10 μl of virus stock missed with 
90 μl of Clyra, diluted Clyra or control.
Mean TCID50/ml:
 • Clyraguard 1:1 at 30 min mean: <7.5 × 101
 • Clyraguard 1:10 at 60 min mean: 5.83 × 104
 • Clyraguard 1:100 at 60 min mean: 5.00 × 104
 • Saline at 60 min mean: 2.25 × 104
 • Boiling saline at 10 min mean: <7.5 × 101
Mukherjee et al.23 Vero-E6 cells infected with  
SARS-CoV-2 with initial viral load from 
5.86–8.19 log TCID50.
Log reduction
 • 8% soap bar total fatty matter 67 at 40°C for 20 s ⩾3.14
 • 8% soap bar total fatty matter 68 at 40°C for 20 s ⩾3.06
 • 8% soap bar total fatty matter 72 at 40°C for 20 s ⩾4.06
 • Liquid cleanser 10% surfactant at 20°C for 20 s ⩾3.10
 • Liquid cleanser 12% surfactant at 20°C for 10 s ⩾3.01
 • Liquid cleanser 19% surfactant at 20°C for 10 s ⩾3.42
 • Alcohol-based sanitiser 60.5% alcohol at 20°C for 10 s ⩾3.25
 • Alcohol-based sanitiser 65% alcohol at 20°C for 10 s ⩾4.01
 • Alcohol-based sanitiser 95% alcohol at 20°C for 15 s ⩾4.01
Smith et al.28 Vero E6 cells infected with SARS-
CoV-2 inoculated on N95 masks (1860, 
1870+, 8511).
Infectivity (ΔRNA in Vero E6 cells from input log 10)
 • Ethanol 1860 undetectable
 • Ethanol 1870+ undetectable
 • Ethanol 8511 undetectable
 • Vaporised hydrogen peroxide 1860 log reduction of −2
 • Vaporised hydrogen peroxide 1870+ log reduction of −2
 • Vaporised hydrogen peroxide 8511 log reduction of 3
 • Ethanol altered mask integrity
Takeda et al.29 Vero E6 cells infected with SARS-
CoV-2 then cultured in growth 
medium with viral titre 5.75–7.25 
log10 TCID50/ml mixed with solutions 
for 1 min at 25°C.
Acidic electrolysed water with free available chlorine 74 ppm for 1 min viral titres 
9:1 ⩾99.99% inactivation and decrease of ⩾4.25 log 10 TCID50/ml inactivation lost 
with 5:1 (decrease ~2 log 10 TCID50/ml)
Welch et al.31 3D printed materials in disks had 
virus (100 μl) added and subjected to 
chemical treatment.
Virus infectivity reduction (log 10) by treatment:
 • 10% bleach >5.5
 • 70% isopropanol 1.4
 • Ammonium quarternary >5.5
 • H2O2 wipe 5.5
TCID, tissue culture infective dose; RNA, ribonucleic acid; PVP-I, Povidine iodine gel.
Table 3. (Continued)
and found that humidity has a profound effect on 
heat inactivation of dried SARS-CoV-2. In par-
ticular, meltblown fabric, a key component of 
N95-grade filtering facepiece respirators, could 
be heated to 75–85°C to inactivate the virus in 
20–30 min under 100% relative humidity without 
lowering filtration efficiency.
Light irradiation
The results from studies evaluating viral inactiva-
tion through ultraviolet light (UV) are shown in 
Table 2. UV light was used at different wave-
lengths including 222 nm, 254 nm, 260–285 nm 
and 365 nm. On N95 masks, Fischer et al.11 found 
that UV light was much slower at reducing virus 
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levels compared with virus on stainless steel 
(128 min versus 9.79 min). For viral suspension, a 
reduction of 2–3 log in virus could be achieved 
with exposure to 222 nm for 30 s and 280 nm light 
at 10 s.16,18,25 On N95 masks, SARS-CoV-2 viral 
load could be reduced by 2–3 log units by irradia-
tion with 254 nm ultraviolet light.28 Simmons et 
al.27 found that virus deposited on chamber slide 
and N95 respirators could be reduced by pulsed-
xenon UV light with more than a 4 log reduction 
at 5 min of exposure. Helingloh et al.13 reported 
that virus in well plates could be inactivated with 
UVC (254 nm) and UVA (365 nm) light (inacti-
vation in 9 min and 50% reduction in 1.4 min). 
Ratnesar-Shumate et al.26 considered simulated 
sunlight on SARS-CoV-2 and found that 90% of 
infectious virus was inactivated every 6.8 min in 
simulated saliva and every 14.3 min in culture 
media when exposed to simulated sunlight.
Chemical agents
The impact of a variety of chemical agents on the 
inactivation of SARS-CoV-2 is shown in Table 3. 
Studies have shown that SARS-CoV-2 could be 
inactivated with viral lysis buffer, guandinium 
thiocynate/t-octylphenoxypolyethoxyethanol, for-
maldehyde, 70% ethanol, vaporised hydrogen 
peroxide, hydrogen peroxide plasma, standard 
autoclaving, peracetic acid dry fogging system, eth-
ylene oxide gassing, 10% bleach, 2% Virkon, lysis 
buffer, AVL, WHO formulation I hand rub, 
advanced hand santiser and disinfecting solution, 
7.5% povidone-iodine, 0.05% chlorhexidine, 0.1% 
benzalkonium chloride treatment, povidone-iodine 
gel, Clyraguard copper iodine complex, 9:1 ratio of 
acidic electrolysed water of pH 2.5 with free avail-
able chlorine 74 ppm, original WHO formulation, 
modified WHO formulation, original WHO for-
mulation II, modified WHO formulation II, 30% 
ethanol and 30% 2-propanolol.5,8,9,11,14,19–22,28,29,31 
However, autoclaving and low-temperature hydro-
gen peroxide gas plasma results in failure of masks 
after three and five or more cycles, respectively.20 In 
the study, by Chan et al.8 of multiple agents, the 
least effective agents (defined as less than a 10-fold 
reduction in the viral load at 5 min of exposure) 
were Mannings hand wash and Walch hand wash. 
Interestingly, 1:49 hand soap required 15 min 
before virus was not detected.9 Ijaz et al.15 studied 
SARS-CoV-2 in suspension and dried on glass and 
found that antiseptic liquid (0.094 w/v para-
chloro-meta-xylenol) for 5 min at 21°C, hand 
sanitiser gel (49% w/w ethanol) for 1 min at 21°C, 
liquid hand wash (0.025% w/w salicylic acid) for 
1 min at 37°C, bar soap (0.018 w/w para-
chloro-meta-xylenol) for 1 min at 38°C, surface 
cleanser (0.077 w/w QAC) for 5 min at 21°C, disin-
fectant wipes (0.19% w/w QAC) for 2 min at 21°C 
and disinfectant spray (50% w/w ethanol QAC) for 
2 min at 21°C all resulted in more than 3.1 log 
reduction in the viral load. Jahromi et al.17 evalu-
ated different solutions of ethanol, isopropanol, 
SDBS, glycerine and soap and found that the most 
effective agents in reducing SARS-CoV-2 were 
combinations of dish soap/ethanol/isopropanol/
water with or without glycerine, which resulted in a 
~7-fold in reduction factor in SARS-CoV-2 suspen-
sion. The least effective were 3% dish soap or hand 
soap and water (1-fold in reduction factor). 
Mukherjee et al.23 studied the impact of various 
concentrations of soap, liquid cleanser and alcohol-
based sanitiser on the reduction of SARS-CoV-2 
and found that use of soap with ⩾67 total fatty 
matter at 40°C for 20 s could reduce virus by more 
than 3 log units while similar reduction could be 
achieved with liquid cleanser of ⩾10% surfactant at 
20°C for 20 s and alcohol-based sanitiser with 
⩾60.5% alcohol at 20°C for ⩾10 s.
Other notable findings
Chin et al.9 also reported the time when the virus 
could not be detected on different surfaces. After 
2–3 h the virus was not detected on paper, tissue 
paper, wood and cloth. However, it could last for 
7 days on stainless steel, plastic and both the inner 
and outer layer of masks, and could be detected 
up to 4 days on glass or bank notes.
Discussion
Our review has several key findings. First, several 
methods are effective in inactivating the SARS-
CoV-2 virus, with these methods broadly classed 
as those related to heating, UV light irradiation 
and chemical agents. Second, all the studies took 
place in laboratory setting rather than real-life 
clinical settings, so there is insufficient evidence 
to recommend one type of cleaning procedure 
over another. Third, there is clear evidence that 
the ability of the virus to remain active depends 
on the environment, as it can last much longer on 
plastic or steel compared with paper or wood. 
Finally, the ideal cleaning or decontamination 
method really depends on what we are trying to 
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make virus free, and to date there are no studies 
detailing how to clean rooms or hospital items 
other than masks. These findings suggest that 
many of the traditional agents that have been 
used to destroy viruses are effective for SARS-
CoV-2, but whether certain approaches should be 
supported in clinical settings is not clear.
We have shown that a variety of different meth-
ods have been tested for their antiviral activities 
for SARS-CoV-2. There are broadly several treat-
ment classes including heat, light irradiation and 
chemical agents. Heat appears to be effective in 
reducing virus, but in terms of clinical practice it 
can only be used for objects that can be placed in 
an autoclave oven or other heating element as 
heating patient rooms and their contents to high 
temperatures is impractical. However, heat can 
potentially damage heat-sensitive materials, espe-
cially when heated to high temperatures for pro-
longed periods. Light irradiation appears to be a 
more novel approach which seems to be effective 
in eliminating virus. Light could be delivered 
from a lamp onto objects or placed in clinical 
environment to decontaminate light-exposed 
areas. However, there appears to be significant 
heterogeneity in the wavelength, power and dura-
tion of light exposure in the studies evaluated. 
There are also risks of damaging items with pro-
longed exposure to high-energy and high-inten-
sity light and a carcinogenic risk to humans, so it 
cannot be used on items patients are wearing or 
as a measure to clean body parts. Reassuringly, 
many typical household items such as soap, 
cleansers and alcohol gel have been shown to 
reduce virus. However, laboratory test conditions 
are very different from real life, as people are not 
guaranteed to wash their hands for 20 s and there 
may be areas which are not adequately washed.32 
At the same time, even if hands are clean, faucet 
taps and door handles may become contaminated 
with virus. An interesting approach is to use 
hydrogen peroxide vapour as a method of decon-
tamination, which appears to be effective to clean 
objects as well as rooms. These methods appear 
to be the best approach to clean rooms but may 
be more expensive compared with simpler meth-
ods. This also has the advantage in that, unlike 
liquid chemicals, it may be effective in cleaning 
airborne or droplet virus in rooms. While we have 
assessed the literature on decontamination more 
studies are needed from the clinical practice set-
ting perspective, including what the ideal cleaning 
procedures are for different healthcare items and 
settings.
It is important to consider that disinfection prod-
ucts may be effective in removing virus but they 
should not cause harm, and these agents are not 
without risks to people and the environment.33 
Since March 2020, there have been increased 
calls to poison centres in the United States for 
exposures to both cleaners and disinfectants such 
as bleach products, non-alcohol disinfectants and 
hand sanitisers.34 While most cases involved 
ingestion and affected children, these increased 
exposures may be related to using more than rec-
ommended on labels, mixing multiple chemical 
products, not wearing protective equipment and 
use in poorly ventilated areas.34 Bleach and hand 
sanitisers can cause irritation of the skin, eyes and 
respiratory tract,33 and some sanitisers had to be 
recalled because of their methanol content which 
can cause vomiting, headaches, blindness, sei-
zures, coma and death.35 In a descriptive study of 
1090 Iranian participants, 87% of participants 
used the incorrect proportion of water and alco-
hol to make disinfectants at home and 42% expe-
rienced at least one disorder of their hands, feet, 
eyes, respiratory or gastrointestinal systems after 
sequential uses of disinfectants.36 Furthermore, 
there are concerns that antibacterial hand sanitis-
ers may contribute to antibiotic resistance in bac-
teria and loss of a barrier to protect against 
coronavirus.37 In the report by Samara et al.33 it 
was suggested that the ideal disinfectant should 
have low toxicity profile with short- and long-
term exposure, and that there is no safe chemical, 
so there is a need to enhance consumer awareness 
and develop disinfectants that are less harmful to 
humans and the environment.
One of the drivers for doing this review was to try 
to understand if there was any evidence regarding 
cleaning rooms where patients had been infected 
with COVID-19, and how they should be cleaned. 
This is important, as a room where a patient with 
COVID-19 had stayed could be a reservoir for 
infecting staff and future patients if it was not 
cleaned adequately. We found no studies that 
evaluated how rooms were cleaned and how they 
should be cleaned. Similarly, there were no evalu-
ations of how other instruments and objects 
should be cleaned aside from N95 respirators. 
While spread of infection by direct contact is 
expected, preventing indirect transmission is 
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more challenging as there is no evidence to guide 
best practice in this area.
Failure to adequately clean areas where patients 
with COVID-19 are present or have been in con-
tact with can have drastic consequences. This 
review suggests that many of the traditional meth-
ods such as heat, irradiation and chemical agents 
effectively employed to decontaminate viruses are 
also effective for SARS-CoV-2. However, it is not 
good enough simply to know that they are effective; 
it is important that these methods are sufficiently 
used to the best degree to eliminate viruses, and 
that the people responsible for cleaning are trained 
properly. Our ability to control the spread of the 
infection is only as strong as the weakest link. It 
may not be the doctors, nurses, and other health-
care professionals such as paramedics or allied 
health professionals, but the administrative team, 
maintenance workers, porters, cleaners, catering 
team or public visitors who may be this weak link. 
Similarly, the problem exists for surfaces and 
objects like stethoscopes, blood pressure cuffs and 
other monitoring equipment, paper notes, key-
boards, ward telephones, curtains, hospitals beds, 
chairs, the floor, and the list goes on. As cleaning is 
a major control component for outbreaks of infec-
tion, lack of vigilance and inadequate cleaning by a 
member of the staff or public will result in the virus 
continuing to spread. Worryingly, some of the most 
important healthcare workers, such as those in 
cleaner roles, have minimal specific training or 
guidance on how to minimise the spread of 
COVID-19. We hope that the research highlighted 
in this review and future work will encourage more 
support for these important key workers.
This review has a few limitations. There are a 
number of different methods of assessing viral 
fomite density, which means that it may be impos-
sible to draw like-for-like comparisons between 
studies. While there are many studies in this 
review, many of the studies were only published 
on pre-print servers or as letters, and may lack 
rigorous peer review or comprehensive detail. 
Although it is understandable that there may be a 
pressing need for information, the quality is 
important, so more high-quality studies are 
needed. In addition, we originally aimed to iden-
tify studies of cleaning from actual clinical set-
tings; however, we only found studies from 
in vitro settings. We hope that this review will 
prompt researchers to focus on this important 
area that has been neglected for future research. 
Furthermore, this review may be limited by pub-
lication bias, as studies which show that agents 
are effective in eradicating the virus are more 
likely to be published compared with those which 
fail to eradicate the virus.
Conclusions
In conclusion, methods including heat, UV light 
irradiation and chemicals can be used to disinfect 
or inactivate SARS-CoV-2, but there is insuffi-
cient evidence to support one measure over oth-
ers in clinical practice. In particular, there is a 
lack of studies from clinical settings about clean-
ing hospital facilities and sterilisation of equip-
ment, so more studies are needed to understand 
how to reduce the spread of COVID-19.
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